AIRDF Stock Chart & Stats
$0.43
>-$0.01(-2.24%)
At close: 4:00 PM EDT
$0.43
>-$0.01(-2.24%)
Day’s Range― - ―
52-Week Range$0.32 - $0.70
Previous CloseN/A
Volume27.22K
Average Volume (3M)37.00K
Market Cap
$33.33M
Enterprise Value$58.25M
Total Cash (Recent Filing)$947.65K
Total Debt (Recent Filing)$1.20M
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding101,262,250
10 Day Avg. Volume46,015
30 Day Avg. Volume36,997
Financial Highlights & Ratios
PEG Ratio-0.21
Price to Book (P/B)15.03
Price to Sales (P/S)30.35
P/FCF Ratio-8.05
Enterprise Value/Market Cap1.75
Enterprise Value/Revenue21.59
Enterprise Value/Gross Profit-7.07K
Enterprise Value/Ebitda-3.01
Forecast
1Y Price Target
$0.90Price Target Upside109.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.09
Revenue Forecast (FY)$2.96M
Bulls Say, Bears Say
Bulls Say
Rapid Revenue ScalingRevenue is scaling rapidly from a small base, indicating growing adoption of the company’s healthcare technology and virtual-care offering. Continued top-line expansion could improve operating leverage over time if growth becomes large enough to absorb the current cost structure.
Digital Health PlatformThe platform combines virtual consultations with AI-enabled clinical workflow support, positioning the company within structurally growing digital-health and health-IT markets. This integrated model can create recurring use cases across patient care delivery and clinician operations.
Limited Non-Cash DistortionFree cash flow being broadly aligned with net loss suggests reported earnings weakness is reflected in actual cash economics rather than driven mainly by large non-cash charges. That improves the transparency of performance, even though the underlying cash result remains negative.
Bears Say
Persistent Large LossesThe company remains deeply unprofitable despite strong revenue growth, showing that its current revenue base does not yet cover operating costs. Persistent large losses can constrain reinvestment, require external funding, and delay the point at which growth translates into sustainable earnings.
Sustained Cash BurnHeavy operating and free-cash-flow losses indicate that the business consumes substantial cash to fund ongoing operations. Unless cash generation improves materially, continued losses may increase dependence on external financing and reduce flexibility to invest in longer-term expansion.
Balance Sheet DeteriorationLeverage has risen sharply as equity fell from approximately $3.51M in 2025 to $0.36M on a TTM basis. The thinner equity cushion and higher debt burden reduce resilience while losses continue, limiting the company’s ability to absorb further deterioration.
Rocket Doctor AI News
AIRDF FAQ
What was Rocket Doctor AI’s price range in the past 12 months?
Rocket Doctor AI lowest stock price was $0.32 and its highest was $0.70 in the past 12 months.
What is Rocket Doctor AI’s market cap?
Rocket Doctor AI’s market cap is $33.33M.
When is Rocket Doctor AI’s upcoming earnings report date?
Rocket Doctor AI’s upcoming earnings report date is Dec 01, 2026 which is in 33 days.
How were Rocket Doctor AI’s earnings last quarter?
Rocket Doctor AI released its earnings results on Aug 31, 2026. The company reported -$0.05 earnings per share for the quarter.
Is Rocket Doctor AI overvalued?
According to Wall Street analysts Rocket Doctor AI’s price is currently Undervalued.
Does Rocket Doctor AI pay dividends?
Rocket Doctor AI does not currently pay dividends.
What is Rocket Doctor AI’s EPS estimate?
Rocket Doctor AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rocket Doctor AI have?
Rocket Doctor AI has 101,262,250 shares outstanding.
What happened to Rocket Doctor AI’s price movement after its last earnings report?
Rocket Doctor AI reported an EPS of -$0.05 in its last earnings report. Following the earnings report the stock price went down -1.199%.
Which hedge fund is a major shareholder of Rocket Doctor AI?
Currently, no hedge funds are holding shares in AIRDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rocket Doctor AI
Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effectively manage their health issues, concerns, and ongoing wellness journey. This sophisticated digital health platform also functions as an insightful assessment tool, offering valuable health analytics. Furthermore, Rocket Doctor AI Inc. provides a range of additional solutions, including medical education resources, tools for medical clinics, expert clinical advisory services, and a comprehensive healthcare information hub. Established in 2018, the company was formerly known as Treatment.com AI Inc. and is slated to officially adopt the name Rocket Doctor AI Inc. in August 2025.
AIRDF Stock 12 Month Forecast
Average Price Target
$0.90
▲(109.18% Upside)